Celldex Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$33.97

+0.65 (+1.95%)

As of May 9, 1:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 86%

Hold 2 9%

Sell 1 5%

Price Target

Analyst Price Target +53.3% upside

Low Target $39.61

Average Target $52.08

High Target $81.09

Current Price $33.97

Current
$33.97

Target
$52.08

$39.61 $52.08 avg $81.09

Scenario Analysis

Bear Case

$39.61

16.6%

Low target

Base Case

$52.08

+53.3%

Avg target

Bull Case

$81.09

+138.7%

High target

Risk/Reward

8.4x

Highly favorable

Price in Context

52-Week High

$35.79

-5.1% from high

52-Week Low

$17.85

+90.3% from low

Target vs 52W High

$52.08

+45.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%